AI Health Technology Limited (HKG:1715)
Hong Kong · Delayed Price · Currency is HKD 0.4650
-0.0100 (-2.11%)
At close: Jun 1, 2026
AI Health Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 47.4 | 91.89 | 84.37 | 88.19 | 143.87 | |
Revenue Growth (YoY) | -48.41% | 8.91% | -4.33% | -38.71% | -24.03% |
Cost of Revenue | 43.14 | 85.4 | 63.15 | 49.7 | 78.6 |
Gross Profit | 4.26 | 6.49 | 21.22 | 38.49 | 65.27 |
Selling, General & Admin | 34.35 | 31.87 | 53.11 | 70.92 | 100.19 |
Research & Development | 5.76 | 5.87 | 6.94 | 7.99 | 10.54 |
Other Operating Expenses | -1.86 | -3.83 | -3.18 | -2.79 | -4.84 |
Operating Expenses | 36.65 | 37.93 | 62.58 | 78.19 | 105.88 |
Operating Income | -32.39 | -31.45 | -41.37 | -39.7 | -40.61 |
Interest Expense | -3.14 | -4.16 | -7.72 | -5.06 | -1.51 |
Interest & Investment Income | 0.42 | 0.01 | 0.01 | 0.06 | 0.09 |
Earnings From Equity Investments | -1.03 | -0.34 | -0.57 | -0.39 | -0.74 |
Currency Exchange Gain (Loss) | 0.16 | -0.55 | 0.05 | -0.94 | -0.95 |
EBT Excluding Unusual Items | -35.96 | -36.49 | -49.59 | -46.03 | -43.72 |
Gain (Loss) on Sale of Investments | - | 0.54 | 0.26 | -3.29 | - |
Gain (Loss) on Sale of Assets | - | - | -0.06 | 6.12 | -0.01 |
Pretax Income | -35.96 | -35.96 | -49.28 | -43.21 | -43.72 |
Income Tax Expense | 0.05 | 0.05 | 0.04 | 0.34 | 0.17 |
Earnings From Continuing Operations | -36.02 | -36.01 | -49.32 | -43.55 | -43.89 |
Minority Interest in Earnings | 0.46 | 0.16 | - | 0.34 | -0.46 |
Net Income | -35.56 | -35.85 | -49.32 | -43.21 | -44.35 |
Net Income to Common | -35.56 | -35.85 | -49.32 | -43.21 | -44.35 |
Shares Outstanding (Basic) | 268 | 715 | 68 | 60 | 60 |
Shares Outstanding (Diluted) | 268 | 715 | 68 | 60 | 60 |
Shares Change (YoY) | -62.48% | 956.92% | 12.70% | - | - |
EPS (Basic) | -0.13 | -0.05 | -0.73 | -0.72 | -0.74 |
EPS (Diluted) | -0.13 | -0.05 | -0.73 | -0.72 | -0.74 |
Free Cash Flow | -10.09 | -35.37 | 14 | -76.7 | -13.24 |
Free Cash Flow Per Share | -0.04 | -0.05 | 0.21 | -1.28 | -0.22 |
Gross Margin | 9.00% | 7.06% | 25.15% | 43.64% | 45.37% |
Operating Margin | -68.32% | -34.23% | -49.03% | -45.02% | -28.23% |
Profit Margin | -75.02% | -39.02% | -58.45% | -49.00% | -30.83% |
Free Cash Flow Margin | -21.29% | -38.50% | 16.59% | -86.97% | -9.20% |
EBITDA | -30.05 | -28.58 | -38.16 | -35.22 | -36.22 |
EBITDA Margin | -63.40% | -31.10% | -45.23% | -39.94% | -25.18% |
D&A For EBITDA | 2.33 | 2.87 | 3.21 | 4.48 | 4.39 |
EBIT | -32.39 | -31.45 | -41.37 | -39.7 | -40.61 |
EBIT Margin | -68.32% | -34.23% | -49.03% | -45.02% | -28.23% |
Advertising Expenses | - | - | - | 3.57 | 8.69 |